The thyroid hormone derivative 3-iodothyronamine (3-T1AM) exerts metabolic
effects in vivo that contradict known effects of thyroid hormones. 3-T1AM acts
as a trace amine-associated receptor 1 (TAAR1) agonist and activates Gs
signaling in vitro. Interestingly, 3-T1AM-meditated in vivo effects persist in
Taar1 knockout-mice indicating that further targets of 3-T1AM might exist.
Here, we investigated another member of the TAAR family, the only scarcely
studied mouse and human trace-amine-associated receptor 8 (Taar8b, TAAR8). By
RT-qPCR and locked-nucleic-acid (LNA) in situ hybridization, Taar8b expression
in different mouse tissues was analyzed. Functionally, we characterized TAAR8
and Taar8b with regard to cell surface expression and signaling via different
G-protein-mediated pathways. Cell surface expression was verified by ELISA,
and cAMP accumulation was quantified by AlphaScreen for detection of Gs and/or
Gi/o signaling. Activation of G-proteins Gq/11 and G12/13 was analyzed by
reporter gene assays. Expression analyses revealed at most marginal Taar8b
expression and no gender differences for almost all analyzed tissues. In
heart, LNA-in situ hybridization demonstrated the absence of Taar8b
expression. We could not identify 3-T1AM as a ligand for TAAR8 and Taar8b, but
both receptors were characterized by a basal Gi/o signaling activity, a so far
unknown signaling pathway for TAARs